111 related articles for article (PubMed ID: 11738742)
1. Induction of hepatitis C virus-specific cytotoxic T lymphocytes in mice by immunization with dendritic cells treated with an anthrax toxin fusion protein.
Moriya O; Matsui M; Osorio M; Miyazawa H; Rice CM; Feinstone SM; Leppla SH; Keith JM; Akatsuka T
Vaccine; 2001 Dec; 20(5-6):789-96. PubMed ID: 11738742
[TBL] [Abstract][Full Text] [Related]
2. Induction of hepatitis C virus-specific cytotoxic T lymphocytes in mice by immunization with dendritic cells transduced with replication-defective recombinant adenovirus.
Matsui M; Moriya O; Abdel-Aziz N; Matsuura Y; Miyamura T; Akatsuka T
Vaccine; 2002 Dec; 21(3-4):211-20. PubMed ID: 12450696
[TBL] [Abstract][Full Text] [Related]
3. Induction of hepatitis C virus-specific cytotoxic T and B cell responses by dendritic cells expressing a modified antigen targeting receptor.
Wang QC; Feng ZH; Zhou YX; Nie QH
World J Gastroenterol; 2005 Jan; 11(4):557-60. PubMed ID: 15641145
[TBL] [Abstract][Full Text] [Related]
4. Targeting of hepatitis C virus core protein for MHC I or MHC II presentation does not enhance induction of immune responses to DNA vaccination.
Vidalin O; Tanaka E; Spengler U; Trépo C; Inchauspé G
DNA Cell Biol; 1999 Aug; 18(8):611-21. PubMed ID: 10463057
[TBL] [Abstract][Full Text] [Related]
5. Co-delivery of GM-CSF gene enhances the immune responses of hepatitis C viral core protein-expressing DNA vaccine: role of dendritic cells.
Ou-Yang P; Hwang LH; Tao MH; Chiang BL; Chen DS
J Med Virol; 2002 Mar; 66(3):320-8. PubMed ID: 11793383
[TBL] [Abstract][Full Text] [Related]
6. Effective induction of type 1 cytotoxic T cell responses in mice with DNA vaccine encoding two hepatitis C virus cytotoxic T lymphocyte epitopes.
Shi L; Liu S; Fan GX; Sheng L; Ren HX; Yuan YK
Viral Immunol; 2006; 19(4):702-11. PubMed ID: 17201665
[TBL] [Abstract][Full Text] [Related]
7. Genetic immunization of wild-type and hepatitis C virus transgenic mice reveals a hierarchy of cellular immune response and tolerance induction against hepatitis C virus structural proteins.
Satoi J; Murata K; Lechmann M; Manickan E; Zhang Z; Wedemeyer H; Rehermann B; Liang TJ
J Virol; 2001 Dec; 75(24):12121-7. PubMed ID: 11711603
[TBL] [Abstract][Full Text] [Related]
8. Cytotoxic T-lymphocyte epitopes fused to anthrax toxin induce protective antiviral immunity.
Doling AM; Ballard JD; Shen H; Krishna KM; Ahmed R; Collier RJ; Starnbach MN
Infect Immun; 1999 Jul; 67(7):3290-6. PubMed ID: 10377103
[TBL] [Abstract][Full Text] [Related]
9. Characterization of hepatitis C virus core-specific immune responses primed in rhesus macaques by a nonclassical ISCOM vaccine.
Polakos NK; Drane D; Cox J; Ng P; Selby MJ; Chien D; O'Hagan DT; Houghton M; Paliard X
J Immunol; 2001 Mar; 166(5):3589-98. PubMed ID: 11207320
[TBL] [Abstract][Full Text] [Related]
10. Whole recombinant yeast-based immunotherapy induces potent T cell responses targeting HCV NS3 and Core proteins.
Haller AA; Lauer GM; King TH; Kemmler C; Fiolkoski V; Lu Y; Bellgrau D; Rodell TC; Apelian D; Franzusoff A; Duke RC
Vaccine; 2007 Feb; 25(8):1452-63. PubMed ID: 17098335
[TBL] [Abstract][Full Text] [Related]
11. In vitro studies of core peptide-bearing immunopotentiating reconstituted influenza virosomes as a non-live prototype vaccine against hepatitis C virus.
Hunziker IP; Grabscheid B; Zurbriggen R; Glück R; Pichler WJ; Cerny A
Int Immunol; 2002 Jun; 14(6):615-26. PubMed ID: 12039913
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis B virus precore protein augments genetic immunizations of the truncated hepatitis C virus core in BALB/c mice.
Liao G; Wang Y; Chang J; Bian T; Tan W; Sun M; Li W; Yang H; Chen J; Zhang X; Bi S; Omata M; Jiang S
Hepatology; 2008 Jan; 47(1):25-34. PubMed ID: 18074356
[TBL] [Abstract][Full Text] [Related]
13. Induction of primary human T cell responses against hepatitis C virus-derived antigens NS3 or core by autologous dendritic cells expressing hepatitis C virus antigens: potential for vaccine and immunotherapy.
Li W; Krishnadas DK; Li J; Tyrrell DL; Agrawal B
J Immunol; 2006 May; 176(10):6065-75. PubMed ID: 16670315
[TBL] [Abstract][Full Text] [Related]
14. High efficiency prokaryotic expression and purification of a portion of the hepatitis C core protein and analysis of the immune response to recombinant protein in BALB/c mice.
Hitomi Y; McDonnell WM; Baker JR; Askari FK
Viral Immunol; 1995; 8(2):109-19. PubMed ID: 8825296
[TBL] [Abstract][Full Text] [Related]
15. Combination of three adjuvants enhances the immunogenicity of a recombinant protein containing the CTL epitopes of non-structural proteins of hepatitis C virus.
Kuprianov VV; Nikolaeva LI; Zykova AA; Dedova AV; Grishechkin AE; Kapustin IV; Kotlyarov RY; Ravin NV
Virus Res; 2020 Jul; 284():197984. PubMed ID: 32325116
[TBL] [Abstract][Full Text] [Related]
16. Targeting HIV proteins to the major histocompatibility complex class I processing pathway with a novel gp120-anthrax toxin fusion protein.
Goletz TJ; Klimpel KR; Arora N; Leppla SH; Keith JM; Berzofsky JA
Proc Natl Acad Sci U S A; 1997 Oct; 94(22):12059-64. PubMed ID: 9342362
[TBL] [Abstract][Full Text] [Related]
17. Priming with two DNA vaccines expressing hepatitis C virus NS3 protein targeting dendritic cells elicits superior heterologous protective potential in mice.
Guan J; Deng Y; Chen H; Yin X; Yang Y; Tan W
Arch Virol; 2015 Oct; 160(10):2517-24. PubMed ID: 26215441
[TBL] [Abstract][Full Text] [Related]
18. Deletion modification enhances anthrax specific immunity and protective efficacy of a hepatitis B core particle-based anthrax epitope vaccine.
Yin Y; Zhang S; Cai C; Zhang J; Dong D; Guo Q; Fu L; Xu J; Chen W
Immunobiology; 2014 Feb; 219(2):97-103. PubMed ID: 24054942
[TBL] [Abstract][Full Text] [Related]
19. Role of furin in delivery of a CTL epitope of an anthrax toxin-fusion protein.
Zhang Y; Kida Y; Kuwano K; Misumi Y; Ikehara Y; Arai S
Microbiol Immunol; 2001; 45(2):119-25. PubMed ID: 11293477
[TBL] [Abstract][Full Text] [Related]
20. Oral immunization with attenuated Salmonella carrying a co-expression plasmid encoding the core and E2 proteins of hepatitis C virus capable of inducing cellular immune responses and neutralizing antibodies in mice.
Cao J; Chen Z; Ren Y; Luo Y; Cao M; Lu W; Zhao P; Qi Z
Vaccine; 2011 May; 29(20):3714-23. PubMed ID: 21396407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
